Crossref
journal-article
Elsevier BV
Seminars in Pediatric Neurology (78)
References
51
Referenced
130
{'key': '10.1016/j.spen.2008.05.008_bib1', 'series-title': 'The Metabolic & Molecular Bases of Inherited Disease', 'first-page': '2297', 'article-title': 'Mitochondrial fatty acid disorders, in', 'author': 'Roe', 'year': '2001'}
/ The Metabolic & Molecular Bases of Inherited Disease / Mitochondrial fatty acid disorders, in by Roe (2001)10.1373/clinchem.2003.022178
/ Clin Chem / Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns by Chace (2003){'key': '10.1016/j.spen.2008.05.008_bib3', 'series-title': 'The Metabolic & Molecular Bases of Inherited Disease', 'first-page': '3219', 'article-title': 'Single peroxisomal enzyme deficiencies, in', 'author': 'Wanders', 'year': '2001'}
/ The Metabolic & Molecular Bases of Inherited Disease / Single peroxisomal enzyme deficiencies, in by Wanders (2001)10.1046/j.1432-1033.2003.03952.x
/ Eur J Biochem / β-oxidation of fatty acids by Ghisla (2004)10.1196/annals.1320.001
/ Ann N Y Acad Sci / The role of the carnitine system in human metabolism by Foster (2004)10.1196/annals.1320.004
/ Ann N Y Acad Sci / Carnitine deficiency disorders in children by Stanley (2004)10.1086/519219
/ Am J Hum Genet / A new genetic disorder in mitochondrial fatty acid β-oxidation: ACAD9 deficiency by He (2007)10.2174/1568008053174796
/ Curr Drug Targets Immune Endocr Metabol Disord / Mitochondrial trifunctional protein defects: Molecular basis and novel therapeutic approaches by Angdisen (2005)10.1203/01.PDR.0000159631.63843.3E
/ Pediatr Res / Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: Impact of expanded newborn screening on their diagnosis and management by Shekhawat (2005)10.1002/ajmg.c.30087
/ Am J Med Genet Part C / Disorders of carnitine transport and the carnitine cycle by Longo (2006)10.1016/S0022-3476(95)70160-5
/ J Pediatr / Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase by Ogier de Baulney (1995)10.1097/01.LAB.0000098428.51765.83
/ Lab Invest / Carnitine palmitoyltransferase II deficiency: A clinical, biochemical, and molecular review by Sigauke (2003)10.1001/archneur.62.1.37
/ Arch Neurol / Muscle carnitine palmitoyltransferase II deficiency by Deschauer (2005)10.1016/j.mam.2004.06.004
/ Mol Aspects Med / Carnitine palmitoyltransferases 1 and 2: Biochemical, molecular and medical aspects by Bonnefont (2004)10.1210/jc.2004-1936
/ J Clin Endocrinol Metab / Peroxisome proliferators activated receptor δ (PPAR δ) agonist but not PPARα corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells by Djouadi (2005)10.1016/j.amjmed.2005.07.064
/ Am J Med / Rhabdomyolysis caused by an inherited metabolic disease: Very long-chain acyl-CoA dehydrogenase deficiency by Voermans (2006)10.1007/PL00008368
/ Eur J Pediatr / Milder childhood form of very long-chain acyl-CoA dehydrogenase deficiency in a 6-year old Japanese boy by Doi (2000)10.7205/MILMED.171.7.657
/ Mil Med / Rhabdomyolysis in the military: Recognizing late-onset very long-chain acyl CoA dehydrogenase deficiency by Hoffman (2006)10.1542/peds.2006-0666
/ Pediatrics / Neonatal screening for very long-chain acyl-CoA dehydrogenase deficiency: Enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels by Liebig (2006)10.1203/PDR.0b013e31816ff6f0
/ Pediatr Res / Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine by Primassin (2008)10.1097/01.gim.0000204472.25153.8d
/ Genet Med / The epidemiology of medium-chain acyl-CoA dehydrogenase deficiency: An update by Grosse (2006)10.1016/S0140-6736(07)60029-4
/ Lancet / Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: A cohort study by Wilcken (2007)10.1016/j.jpeds.2005.12.028
/ J Pediatr / The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: Clinical presentation and outcome by Derks (2006)10.1093/clinchem/43.11.2106
/ Clin Chem / Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry by Chace (1997)10.1136/adc.80.5.459
/ Arch Dis Child / Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis by Wilson (1999)10.1001/jama.296.8.943
/ JAMA / Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency by van Maldegem (2006)10.1542/peds.112.5.1152
/ Pediatrics / Short-chain acyl-CoA dehydrogenase deficiency: Studies in a large family adding to the complexity of the disorder by Bok (2003)10.1016/S0022-3476(95)70207-5
/ J Pediatr / Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency by Bhala (1995)10.1172/JCI112953
/ J Clin Invest / Short-chain acyl-coenzyme A dehydrogenase deficiency by Amendt (1987)10.1016/S0022-3476(95)70505-8
/ J Pediatr / Transient organic aciduria and persistent lacticacidemia in a patient with short-chain acyl-coenzyme A dehydrogenase deficiency by Dawson (1995)10.1111/j.1742-4658.2005.04911.x
/ FEBS J / 3-Hydroxyacyl-coA dehydrogenase and short chain 3-hydroxyacyl-coA dehydrogenase in human health and disease by Yang (2005)10.1172/JCI200111294
/ J Clin Invest / Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion by Clayton (2001)10.1203/00006450-199601000-00031
/ Pediatr Res / Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: A new defect of fatty acid oxidation by Bennett (1996)10.1038/ncpendmet0368
/ Nat Clin Pract Endocrinol Metab / Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates by De León (2007)10.1111/j.1651-2227.1999.tb01089.x
/ Acta Paediatr / Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by Tyni (1999)10.1542/peds.109.1.99
/ Pediatrics / Heymans SA, Wijburg FA by den Boer (2002)10.1097/01.LAB.0000021175.50201.46
/ Lab Invest / Long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: A molecular and biochemical review by Rakheja (2002)10.1203/01.PDR.0000141967.52759.83
/ Pediatr Res / Mitochondrial fatty acid β-oxidation in the human eye and brain: Implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by Tyni (2004)10.1203/01.PDR.0000161413.42874.74
/ Pediatr Res / Long-chain fatty acid oxidation during early human development by Oey (2005)10.1016/S0022-3476(97)70312-3
/ J Pediatr / Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: Clinical presentation of thirteen patients by Tyni (1997)10.1136/adc.85.6.487
/ Arch Dis Child / Feeding difficulties in long-chain 3-hydroxyacyl-Coa dehydrogenase deficiency by Lund (2001)10.1212/WNL.52.3.640
/ Neurology / Long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency neuropathy: Response t cod liver oil by Tein (1999)10.1172/JCI115983
/ J Clin Invest / Combined enzyme defect of mitochondrial fatty acid oxidation by Jackson (1992)10.1016/0006-291X(92)91350-Y
/ Biochem Biophys Res Commun / Human trifunctional protein deficiency: A new disorder of mitochondrial fatty acid beta-oxidation by Wanders (1992)10.1002/mus.10500
/ Muscle Nerve / Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein by Spiekerkoetter (2004)10.1067/mpd.2003.231
/ J Pediatr / Mitochondrial trifunctional protein deficiency: A severe fatty acid oxidation disorder with cardiac and neurologic involvement by Den Boer (2003)10.1046/j.1442-200x.2004.01861.x
/ Pediatr Int / Mitochondrial trifunctional protein deficiency in a lethal neonate by Yamazaki (2004)10.1007/s00431-002-1035-4
/ Eur J Pediatr / Complete deficiency of mitochondrial trifunctional protein due to a novel mutation within the β-subunit of the mitochondrial trifunctional protein gene leads to failure of long-chain fatty acid β-oxidation with fatal outcome by Schwab (2003)10.1373/clinchem.2005.062000
/ Clin Chem / Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene by Das (2006)10.1016/j.abb.2004.10.018
/ Arch Biochem Biophys / Studies of human mitochondrial 2,4-dienoyl-CoA reductase by Yu (2005)10.1172/JCI114624
/ J Clin Invest / 2,4-Dienoyl-coenzyme A reductase deficiency: A possible new disorder of fatty acid oxidation by Roe (1990)
@article{Kompare_2008, title={Mitochondrial Fatty-Acid Oxidation Disorders}, volume={15}, ISSN={1071-9091}, url={http://dx.doi.org/10.1016/j.spen.2008.05.008}, DOI={10.1016/j.spen.2008.05.008}, number={3}, journal={Seminars in Pediatric Neurology}, publisher={Elsevier BV}, author={Kompare, Michelle and Rizzo, William B.}, year={2008}, month=sep, pages={140–149} }